Diabetic retinopathy (DR) and retinopathy of prematurity (ROP) present two examples of proliferative retinopathy, characterized by the same stages of progression; ischemia of the retinal vessels, leads to hypoxia and to correct the problem there is the setting up of uncontrolled angiogenesis, which subsequently causes blindness or even detachment of the retina. The difference is the following; that DR initiated by the metabolic complications that are due to hyperglycemia, and ROP is induced by overexposure of the neonatal retina to oxygen. In this review, we will demonstrate the physiopathological mechanism of the two forms of proliferative retinopathy DR and ROP, in particular the role of the CD40/CD40L axis and IL-1 on vascular complications and onset of inflammation of the retina, the implications of their effects on the onset of pathogenic angiogenesis, thus understanding the link between platelets and retinal ischemia. In addition, what are the therapeutic targets that could slow its progression?El texto completo de este artículo está disponible en PDF.
Abbreviations : AGE, ANG, APCs, APJ, ATP, CCL2, DR, ECFC, EPO, EPOR, FGF, gp39, GPCR, HIF, HREC, ICAM1, IGF-1, IL-1, IL-1R, Jak3, Mac-1, MAPK, MCC950, MCP-1, MiRNA-126, MMP, MPV, MV, NFκB, NLRP3, NO, NOS, OIR, P75NTR, PAF, PAR2/ F2RL1, PCT, PDGF, PDW, PHD, PI3K, PKC, PLCR, PLCγ, PMV, PSGL-1, PTAFR, REP, ROP, ROS, RP, RPE, RTK, sCD40L, Sema 3A, SiRNA, STAT5, TF, TIMPs, TNFR, TNFα, TRAF, VCAM-1, VEGF, VEGFR, α5β1, αIIbβ3
Keywords : Proliferative retinopathy, CD40, CD40L, IL-1, Platelets
Vol 67 - N° 2P. 62-71 - mai 2019 Regresar al número
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción o una compra individual.